Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05780528
Other study ID # P.T.REC/012/004235
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date March 25, 2023
Est. completion date June 30, 2023

Study information

Verified date March 2023
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

this study will be conducted to compare between mulligan mobilization and instrument assisted soft tissue mobilization on pain intensity, range of motion, hand grip strength, and hand function in the treatment of chronic lateral epicondylitis


Description:

Lateral epicondylitis is one of the elbow conditions that affects about 1-3% of the population at large. It produces a heavy burden of workdays lost and residual impairments. Although many treatment modalities are used, few of them rest on scientific evidence and none has been proven more effective than the others. This lack of evidence on treatments for lateral epicondylitis may stem from several sources, including the possible self-limiting nature of the condition, the lack of pathophysiological data, the methodological shortcomings of available studies, and the existence of numerous factors influencing the outcome. The physiotherapeutic treatment has been shown to be effective. In general, it must include manual therapy to relieve the pain and improve the joint's range of motion (ROM), taking into account that it must be performed under the pain threshold. Mulligan mobilization with movement (MWM) is a modern technique developed by Mulligan for treating lateral epicondylitis (LE). Instrument-assisted soft tissue mobilization is a form of augmented soft tissue mobilization (IASTM) in which stainless steel instruments are utilized to apply controlled microtrauma to the affected soft tissues. sixty patients will be allocated randomly to three groups; the first one will receive mulligan mobilization with movement, the second one will receive instrument-assisted soft tissue mobilization and the third one will receive traditional therapy three times a week for four weeks


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date June 30, 2023
Est. primary completion date June 30, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: All patients will be diagnosed with chronic lateral epicondylitis from both genders. Patients with chronic lateral epicondylitis were diagnosed by orthopedists. Positive clinical manifestation in all patients. Patients' age will be ranged from 18 to 80 years, Pain onset is more than 3 months. All participants must be medically stable and not be treated with analgesics or any medication which may cause misleading results. All patients have a body mass index between 18.5 and 29.9 kg/m2. Exclusion Criteria: Patients who received an intra-articular injection for a duration of less than 3 months. Patients receiving oral or injected corticosteroids for the last 3 months at least. History of elbow surgery/fracture. Acute synovitis/arthritis including infectious. Presence of malignancy. Pregnancy. Patients with, topical lesions, contact dermatitis, and a history of cutaneous hypersensitivity

Study Design


Related Conditions & MeSH terms


Intervention

Other:
mulligan mobilization
The patients will receive mobilization with movement technique of lateral glide. the patients will be in supine subject and pronate forearm, during the application of the lateral glide by the physiotherapist, each patient was asked to perform the closure of the fist (provocative but painless gesture in the execution of the technique) for 3 sets of 10 repetitions.
instrumented assisted soft tissue mobilization
the participant will receive instrumented assisted soft tissue mobilization. The participant's elbow will rest on a table. A lubricant (Vaseline) will be applied to the skin around the elbow prior to treatment and the blade will be cleaned with an alcohol pad. First, the blade will be used to find the exact areas of restriction in the common extensor origin. Then the M2T blade will be used in the treatment planes 1, 2, and 3, to apply slow strokes along the muscle, without causing any discomfort or pain, from the muscle origin to its insertion (sweeping technique)
conventional treatment
the patients will receive conventional treatment in the form of Ultrasound therapy, conventional transcutaneous electrical nerve stimulation (TENS) - hot pack - stretching and strengthening exercises and wrist rest splints

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Outcome

Type Measure Description Time frame Safety issue
Primary pain intensity pain will be measured by visual analogue scale. It is a vertical or horizontal 100 mm line graduated by different levels of pain, starting from 0 (no pain) till 100 (worst pain) up to four weeks
Primary shoulder disability The Arabic version of Disabilities of arm, shoulder, and hand (DASH) will be used for assessing shoulder function.DASH questionnaire includes 11 items with score from 0 to 100. A score of 0 represents no disability, while a score of 100 represents the most sever up to four weeks
Secondary range of motion elbow and wrist range of motion will be measured by universal goniometer up to four weeks
Secondary hand grip strength Hand held dynamometer will be used to measure hand grip strength up to four weeks
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02308514 - Does Adding Cryostimulation to Conservative Care Help in Managing Chronic Lateral Epicondylitis? a Pilote Study N/A
Completed NCT02596659 - Effectiveness of Radial Extracorporeal Shockwave Therapy on Tennis Elbow N/A
Completed NCT00674622 - Prolotherapy for the Treatment of Chronic Lateral Epicondylitis Phase 2/Phase 3
Completed NCT06206109 - The Effect of Tendon Tears on Lateral Epicondylitis
Completed NCT06301152 - Lateral Epicondylitis Treatment High Intensive Laser Therapy and Extracorporeal Shock Wave Therapy N/A
Not yet recruiting NCT04382144 - Levobupivacaine Versus Liposomal Bupivacaine (Exparel®) for Treatment of Pain and Disability in Lateral Epicondylitis Phase 4
Recruiting NCT03863847 - A Neurofeedback Treatment for Chronic Musculoskeletal Pain N/A
Recruiting NCT05648032 - PLT and Steroid in Lateral Epicondylopathy and Supraspinatus Calcific Tendinopathy Phase 3
Completed NCT06300749 - Effectiveness of Chiropractic Cervical Manipulation in Lateral Epicondylitis N/A
Completed NCT00794976 - Dexamethasone Iontophoretic Patch for the Treatment of Pain Associated With Lateral Epicondylitis Phase 2
Completed NCT00888225 - Tennis Elbow Trial N/A
Completed NCT06087081 - Mills Manipulation and Mulligan PRP Affect Pain, Grip Strength and Function on Lateral Epicondylitis N/A
Completed NCT05602571 - The Effectiveness of the Combination of PRP and ESWT in Lateral Epicondylitis N/A
Completed NCT05566418 - Immediate and Longterm Effects of Mulligan Mobilization With and Without Myofascial Release on Pain,Grip Strength and Function in Patients With Lateral Epicondylitis N/A
Not yet recruiting NCT03279796 - Treatment of Tendon Disease Using Autologous Adipose-derived Mesenchymal Stem Cells Phase 2
Completed NCT04687943 - Comparison of PELOID Therapy and Kinesio Tape Effectiveness in Patients With Lateral Epicondylitis
Recruiting NCT05947968 - Scapular PNF Versus Shoulder Strengthening Exercises in Patients With Lateral Epicondylitis. N/A
Active, not recruiting NCT06438328 - Effectiveness of Scapular Muscle Training in Improving Grip Strength Among Lateral Epicondylitis Patients N/A
Completed NCT06317545 - Effects of Nerchal Exercises on Lateral Epicondylitis. N/A
Completed NCT05070559 - Active Release Technique and Graston Technique in Patients With Lateral Epicondylitis N/A